COSCIENS Biopharma Inc. Finance Costs
COSCIENS Biopharma Inc. (CSCIF) reported Finance Costs of $168.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-25
- COSCIENS Biopharma Inc. finance costs for the quarter ending 2025-12-31 was $32.00K, a 39.13% increase year-over-year.
- COSCIENS Biopharma Inc. finance costs for the quarter ending 2025-09-30 was $43.00K, a 95.45% increase year-over-year.
- COSCIENS Biopharma Inc. finance costs for the quarter ending 2025-06-30 was $23.00K, a 4.55% increase year-over-year.
- COSCIENS Biopharma Inc. finance costs for the quarter ending 2025-03-31 was $70.00K, a 11.11% increase year-over-year.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 9 month | Finance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $32.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $75.00K derived: sum of 2 quarters · filed 2026-03-25 | $98.00K derived: sum of 3 quarters · filed 2026-03-25 | $168.00K 20-F · filed 2026-03-25 |
| 2025-09-30 | $43.00K 6-K · filed 2025-11-12 | $66.00K derived: sum of 2 quarters · filed 2025-11-12 | $136.00K 6-K · filed 2025-11-12 | $159.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $23.00K 6-K · filed 2025-08-14 | $93.00K 6-K · filed 2025-08-14 | $116.00K derived: sum of 3 quarters · filed 2026-03-25 | $138.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $70.00K 6-K · filed 2025-05-13 | $93.00K derived: sum of 2 quarters · filed 2026-03-25 | $115.00K derived: sum of 3 quarters · filed 2026-03-25 | $137.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $23.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $45.00K derived: sum of 2 quarters · filed 2026-03-25 | $67.00K derived: sum of 3 quarters · filed 2026-03-25 | $129.00K 20-F · filed 2026-03-25 |
| 2024-09-30 | $22.00K 6-K · filed 2025-11-12 | $44.00K derived: sum of 2 quarters · filed 2025-11-12 | $106.00K 6-K · filed 2025-11-12 | $130.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $22.00K 6-K · filed 2025-08-14 | $85.00K 6-K · filed 2025-08-14 | $108.00K derived: sum of 3 quarters · filed 2026-03-25 | $131.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $63.00K 6-K · filed 2025-05-13 | $86.00K derived: sum of 2 quarters · filed 2026-03-25 | $109.00K derived: sum of 3 quarters · filed 2026-03-25 | $133.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $23.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $46.00K derived: sum of 2 quarters · filed 2026-03-25 | $70.00K derived: sum of 3 quarters · filed 2026-03-25 | $136.00K 20-F · filed 2026-03-25 |
| 2023-09-30 | $23.00K 6-K · filed 2024-11-12 | $47.00K derived: sum of 2 quarters · filed 2024-11-12 | $113.00K 6-K · filed 2024-11-12 | |
| 2023-06-30 | $24.00K 6-K · filed 2024-08-13 | $90.00K 6-K · filed 2024-08-13 | ||
| 2022-12-31 | $143.00K 20-F · filed 2025-04-09 |